Integra LifeSciences to Present At Five Conferences in March


PLAINSBORO, N.J., Feb. 20, 2008 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at five conferences in March.

On March 4, 2008 at 9:30 AM, Gerard Carlozzi, Chief Operating Officer of Integra, will be presenting at CanaccordAdams Small-Cap Orthopedics Conference at The Mission Bay Conference Center at UCSF in San Francisco, CA.

Also on March 4 at 10:25 AM, John B. Henneman, III, Chief Administrative Officer and Acting Chief Finance Officer of Integra, will be presenting at Raymond James & Associates 29th Annual Institutional Investors Conference at the Hyatt Regency Grand Cypress in Orlando, FL.

On the following day, March 5, at 10 AM, Stuart Essig, Chief Executive Officer of Integra will be presenting at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference at the W Hotel in New York, NY.

Gerard Carlozzi will again be presenting on March 17 at 11:30 AM at Cowen and Company's 28th Annual Healthcare Conference at The Boston Marriott Copley Place in Boston, MA.

Stuart Essig will be presenting on March 18 at 2:25 PM at Citi Investment Research, The 5th Annual Small & Midcap Conference at the Four Seasons Hotel in Las Vegas, NV.

Webcasts for the March 4th and March 17th presentations will be accessible through a link provided in the Investor Relations section of Integra's website at http://www.integra-LS.com. Additionally, a replay of each of these webcasts will be available for two weeks following the live event.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products, used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery, are used to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at (http://www.Integra-LS.com).

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2006 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.

IART-G



            

Tags


Contact Data